Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lung cancer

Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lung cancer

Bibliographic Details
Main Authors:	Minami, Seigo, Kijima, Takashi, Shiroyama, Takayuki, Okafuji, Kohei, Hirashima, Tomonori, Uchida, Junji, Imamura, Fumio, Osaki, Tadashi, Nakatani, Takeshi, Ogata, Yoshitaka, Yamamoto, Suguru, Namba, Yoshinobu, Otsuka, Tomoyuki, Tachibana, Isao, Komuta, Kiyoshi, Kawase, Ichiro
Format:	Online
Language:	English
Published:	BioMed Central 2013
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549766/

Similar Items

Sequential Therapy with Gemcitabine and Carboplatin Followed by Paclitaxel as First Line Treatment for Advanced Urothelial Cancer
by: Kattan, Joseph G, et al.
Published: (2012)

Sequential Therapy with Gemcitabine and Carboplatin Followed by Paclitaxel as First Line Treatment for Advanced Urothelial Cancer
by: Joseph G Kattan, Celine Y Boutros, Fadi S Farhat, Georges Y Chahine, Khaled M Musallam, Marwan G Ghosn
Published: (2012-01-01)

Comment on ‘The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer‘
by: Kitchen, D, et al.
Published: (2013)

Bevacizumab in combination with gemcitabine and carboplatin in recurrent ovarian cancer: a critical consideration
by: Giovannoni, Sara, et al.
Published: (2014)

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer
by: Koie, Takuya, et al.
Published: (2014)

Anti-Bv8 Antibody and Metronomic Gemcitabine Improve Pancreatic Adenocarcinoma Treatment Outcome Following Weekly Gemcitabine Therapy12
by: Hasnis, Erez, et al.
Published: (2014)

Effects of sequential paclitaxel–carboplatin followed by gemcitabine-based chemotherapy compared with paclitaxel-carboplatin therapy administered to patients with advanced epithelial ovarian cancer: A retrospective, STROBE-compliant study
by: Wang, Fei, et al.
Published: (2016)

A phase II trial of gemcitabine plus carboplatin in advanced transitional cell carcinoma of the urothelium
by: Xu, Nong, et al.
Published: (2007)

Gemcitabine Plus Carboplatin in Patients with Advanced Hepatocellular Carcinoma: Results of a Phase II Study
by: Azmy, Aly M., et al.
Published: (2012)

Re-challenge chemotherapy with gemcitabine plus carboplatin in patients with non-small cell lung cancer
by: Khan, Khurum, et al.
Published: (2013)

Gemcitabine and carboplatin demonstrate synergistic cytotoxicity in cervical cancer cells by inhibiting DNA synthesis and increasing cell apoptosis
by: Jin, Guixiu, et al.
Published: (2013)

Commentary: Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer
by: Kunos, Charles A.
Published: (2016)

Phase I Trial of Carboplatin and Gemcitabine Chemotherapy and Stereotactic Ablative Radiosurgery for the Palliative Treatment of Persistent or Recurrent Gynecologic Cancer
by: Kunos, Charles A., et al.
Published: (2015)

A case of recurrent malignant fibrous histiocytoma with marked response to combined chemotherapy with gemcitabine and carboplatin
by: Wei, Zhang, et al.
Published: (2014)

A randomized phase II clinical trial of nab-paclitaxel and carboplatin compared with gemcitabine and carboplatin as first-line therapy in locally advanced or metastatic squamous cell carcinoma of lung
by: Yang, Jin-Ji, et al.
Published: (2014)

Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer
by: Rajan, Narayan, et al.
Published: (2014)

Gemcitabine Therapy in Patients with Advanced Pancreatic Cancer
by: Min, Young Joo, et al.
Published: (2002)

Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
by: Chiorean, E Gabriela, et al.
Published: (2016)

Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
by: Li, Doudou, et al.
Published: (2015)

Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
by: Chiorean, E Gabriela, et al.
Published: (2016)

Thrombotic Thrombocytopenic Purpura and Gemcitabine
by: Kasi, Pashtoon Murtaza
Published: (2011)

Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial
by: Yardley, Denise A., et al.
Published: (2015)

Erratum to: ‘Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial
by: Yardley, Denise A., et al.
Published: (2016)

Role of Gemcitabine and Pemetrexed as Maintenance Therapy in Advanced NSCLC: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Hu, Xingsheng, et al.
Published: (2016)

Successful mammalian target of rapamycin inhibitor maintenance therapy following induction chemotherapy with gemcitabine and doxorubicin for metastatic sarcomatoid renal cell carcinoma
by: NUMAKURA, KAZUYUKI, et al.
Published: (2014)

Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
by: Stemmler, H J, et al.
Published: (2011)

Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)
by: Heinrich, Stefan, et al.
Published: (2011)

Zidovudine, an anti-viral drug, resensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine by inhibition of the Akt-GSK3β-Snail pathway
by: Namba, T, et al.
Published: (2015)

Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin–gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study
by: Borget, Isabelle, et al.
Published: (2014)

Pancreas Cancer Survival in the Gemcitabine Era
by: Wachtel, Mitchell S., et al.
Published: (2008)

The role of gemcitabine in the treatment of other tumours.
by: Carmichael, J.
Published: (1998)

Gemcitabine induced hemolytic uremic syndrome
by: Sadjadi, Seyed-Ali, et al.
Published: (2012)

Gemcitabine-Induced Extensive Skin Necrosis
by: D'epiro, Sara, et al.
Published: (2012)

Analysis of the antitumor activity of gemcitabine and carboplatin against ovarian clear-cell carcinoma using the DNA damage marker γH2AX
by: Takatori, Eriko, et al.
Published: (2013)

Serum C-reactive protein level is a significant prognostic indicator in patients with advanced urothelial cancer treated with gemcitabine-cisplatin or carboplatin – preliminary results
by: Morizane, Shuichi, et al.
Published: (2012)

Effectiveness of treatment with endostatin in combination with emcitabine, carboplatin, and gemcitabine in patients with advanced non-small cell lung cancer: a retrospective study
by: Yu Xun, et al.
Published: (2018-04-01)

A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study
by: Nakai, Y, et al.
Published: (2012)

H19-Promoter-Targeted Therapy Combined with Gemcitabine in the Treatment of Pancreatic Cancer
by: Sorin, Vladimir, et al.
Published: (2012)

Inhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma
by: Gong, Dao-Jun, et al.
Published: (2013)

High-intensity focused ultrasound therapy in combination with gemcitabine for unresectable pancreatic carcinoma
by: Lv, Wei, et al.
Published: (2016)